Blood transfusions save lives. In the US alone, people receive around 10 million units each year. But blood banks are always short in supply—especially...
DUBLIN–(BUSINESS WIRE)–The “Nanomaterials in Personalized Medicine: Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The global market for nanomaterials in personalized medicine was valued...
HONG KONG, Sept 13, 2023 - (ACN Newswire) - Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK),...
TOKYO, Aug 08, 2023 - (JCN Newswire) - Aichi Cancer Center and NEC Corporation's research group with Gifu University, Toyama University and Kitasato University...
Ask a cancer researcher what the breakthrough treatment of the decade is, and they’ll tell you CAR T takes the crown.The therapy genetically engineers...
HEIDLEBERG, Germany, Apr 4, 2023 - (ACN Newswire) - BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to...
AI is helping scientists discover new antibodies that could trigger our own immune systems into destroying cancer cells.
The immune system produces antibodies, specialised proteins...
SAN DIEGO–(BUSINESS WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate Therapeutics, Inc. (NASDAQ: FATE) securities between April 2, 2020...
HONG KONG, Dec 19, 2022 - (ACN Newswire) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-based...
Treatment with PDC*lung01 induces anti-tumor immune response in significant number of patients which appears to be enhanced by combination with pembrolizumab
LIÈGE, Belgium, & GRENOBLE,...
IMV’s common shares expected to begin trading on a split-adjusted basis on December 13, 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.–(BUSINESS WIRE)–$IMV #DeliveryPlatform–IMV Inc. (the...
